Completed
A Clinical Study in Infants to Assess the Tolerability of Three Wash Products
What is being tested
Test shampoo
+ Test bath foam
+ Test head to toe wash
Other
Who is being recruted
+9 Eligibility Criteria
How is the trial designed
Basic Science Study
Interventional
Study Start: March 2015
Summary
Principal SponsorGlaxoSmithKline
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: March 1, 2015
Actual date on which the first participant was enrolled.This will be a single centre, evaluator blind, randomized, parallel group, stratified, two week study in healthy participants. The clinical study is designed to provide reassurance that the formulations developed for children and babies with mild to moderately dry skin and for children whose skin is prone to atopic dermatitis (eczema) are well tolerated in the target population, babies and young children with dry skin.
Official TitleA Clinical Study in Infants to Assess the Tolerability of Three Wash Products
Principal SponsorGlaxoSmithKline
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
32 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Basic science studies help researchers understand how the body works or how a disease develops. They don't test treatments, but they build the foundation for future therapies.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Any sex
Biological sex of participants that are eligible to enroll.Range of ages for which participants are eligible to join.
Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
3 inclusion criteria required to participate
Participants up to 18 months of age at the screening/baseline visit with good general health and no major physical disabilities
Parent/legal guardian reported dry skin
Voluntary written informed consent form by parent/legal guardian as an evidence to understanding of the study and willingness to participate
6 exclusion criteria prevent from participating
Allergy/intolerance or hypersensitivity to the study material or any of their stated ingredients
Participant with skin condition that warrants medical intervention, current episode of eczema/atopic dermatitis or has had an episode in the 3 months prior to screening, not regular use of moisturizers (variable application frequency)
Use of oral corticosteroids/immunosuppressive medication within 4 weeks or topical corticosteroids/topical anti-itch products within 2 weeks of baseline
Child in Care; participants' previous participation in this study/another clinical study/receipt of investigational drug within 30 days of the screening visit
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalParticipants' will be instructed to use the test product as per the label instructions for a minimum of twice per week for 2 weeks.
Group II
ExperimentalParticipants' will be instructed to use the test product as per the label instructions for a minimum of twice per week for 2 weeks.
Group III
ExperimentalParticipants' will be instructed to use the test product as per the label instructions for a minimum of twice per week for 2 weeks.
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
CompletedOne Study Center